137 related articles for article (PubMed ID: 38345388)
1. Identification of genetic determinants of bedaquiline resistance in
Umpeleva T; Chetverikova E; Belyaev D; Eremeeva N; Boteva T; Golubeva L; Vakhrusheva D; Vasilieva I
Microbiol Spectr; 2024 Mar; 12(3):e0374923. PubMed ID: 38345388
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants and their association with phenotypic resistance to bedaquiline in
Ismail N; Rivière E; Limberis J; Huo S; Metcalfe JZ; Warren RM; Van Rie A
Lancet Microbe; 2021 Nov; 2(11):e604-e616. PubMed ID: 34796339
[TBL] [Abstract][Full Text] [Related]
3. Reduced susceptibility and resistance to bedaquiline in clinical M. tuberculosis isolates.
Peretokina IV; Krylova LY; Antonova OV; Kholina MS; Kulagina EV; Nosova EY; Safonova SG; Borisov SE; Zimenkov DV
J Infect; 2020 May; 80(5):527-535. PubMed ID: 31981638
[TBL] [Abstract][Full Text] [Related]
4. Primary Bedaquiline Resistance Among Cases of Drug-Resistant Tuberculosis in Taiwan.
Wu SH; Chan HH; Hsiao HC; Jou R
Front Microbiol; 2021; 12():754249. PubMed ID: 34745058
[TBL] [Abstract][Full Text] [Related]
5. Variants associated with Bedaquiline (BDQ) resistance identified in Rv0678 and efflux pump genes in Mycobacterium tuberculosis isolates from BDQ naïve TB patients in Pakistan.
Saeed DK; Shakoor S; Razzak SA; Hasan Z; Sabzwari SF; Azizullah Z; Kanji A; Nasir A; Shafiq S; Ghanchi NK; Hasan R
BMC Microbiol; 2022 Feb; 22(1):62. PubMed ID: 35209842
[TBL] [Abstract][Full Text] [Related]
6. Bedaquiline- and clofazimine- selected Mycobacterium tuberculosis mutants: further insights on resistance driven largely by Rv0678.
Snobre J; Villellas MC; Coeck N; Mulders W; Tzfadia O; de Jong BC; Andries K; Rigouts L
Sci Rep; 2023 Jun; 13(1):10444. PubMed ID: 37369740
[TBL] [Abstract][Full Text] [Related]
7. Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis.
Nimmo C; Millard J; van Dorp L; Brien K; Moodley S; Wolf A; Grant AD; Padayatchi N; Pym AS; Balloux F; O'Donnell M
Lancet Microbe; 2020 Aug; 1(4):e165-e174. PubMed ID: 32803174
[TBL] [Abstract][Full Text] [Related]
8. Bedquiline Resistance Mutations: Correlations with Drug Exposures and Impact on the Proteome in M. tuberculosis.
Xu J; Li D; Shi J; Wang B; Ge F; Guo Z; Mu X; Nuermberger E; Lu Y
Antimicrob Agents Chemother; 2023 Jul; 67(7):e0153222. PubMed ID: 37255473
[TBL] [Abstract][Full Text] [Related]
9. Validation of bedaquiline drug-susceptibility testing by BACTEC MGIT 960 system for
Sivaramakrishnan G; Subramanyam B; Kumar MP; Golla R; Tripathy SP; Mondal R
Int J Mycobacteriol; 2019; 8(4):329-332. PubMed ID: 31793501
[TBL] [Abstract][Full Text] [Related]
10. Whole Genome Sequencing Identifies Novel Mutations Associated With Bedaquiline Resistance in
Guo Q; Bi J; Lin Q; Ye T; Wang Z; Wang Z; Liu L; Zhang G
Front Cell Infect Microbiol; 2022; 12():807095. PubMed ID: 35694543
[TBL] [Abstract][Full Text] [Related]
11. Molecular characteristics and in vitro susceptibility to bedaquiline of Mycobacterium tuberculosis isolates circulating in Shaanxi, China.
Yang J; Pang Y; Zhang T; Xian X; Li Y; Wang R; Wang P; Zhang M; Wang J
Int J Infect Dis; 2020 Oct; 99():163-170. PubMed ID: 32738481
[TBL] [Abstract][Full Text] [Related]
12.
Degiacomi G; Sammartino JC; Sinigiani V; Marra P; Urbani A; Pasca MR
Front Microbiol; 2020; 11():559469. PubMed ID: 33042066
[TBL] [Abstract][Full Text] [Related]
13.
Ismail N; Ismail NA; Omar SV; Peters RPH
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138569
[TBL] [Abstract][Full Text] [Related]
14. Bedaquiline Resistance and Molecular Characterization of Rifampicin-Resistant
Tong E; Zhou Y; Liu Z; Zhu Y; Zhang M; Wu K; Pan J; Jiang J
Infect Drug Resist; 2023; 16():6951-6963. PubMed ID: 37928607
[TBL] [Abstract][Full Text] [Related]
15. Delamanid and bedaquiline resistance patterns in
Akbari Aghababa A; Nasiri MJ; Pakzad P; Mirsamadi ES
New Microbes New Infect; 2024; 60-61():101437. PubMed ID: 38873345
[TBL] [Abstract][Full Text] [Related]
16. Bedaquiline resistance pattern in clofazimine-resistant clinical isolates of tuberculosis patients.
Shang Y; Chen S; Shi W; Nie W; Jing W; Huo F; Xue Y; Dong L; Jiang G; Huang H; Chu N
J Glob Antimicrob Resist; 2023 Jun; 33():294-300. PubMed ID: 37142094
[TBL] [Abstract][Full Text] [Related]
17. Examination of bedaquiline- and linezolid-resistant Mycobacterium tuberculosis isolates from the Moscow region.
Zimenkov DV; Nosova EY; Kulagina EV; Antonova OV; Arslanbaeva LR; Isakova AI; Krylova LY; Peretokina IV; Makarova MV; Safonova SG; Borisov SE; Gryadunov DA
J Antimicrob Chemother; 2017 Jul; 72(7):1901-1906. PubMed ID: 28387862
[TBL] [Abstract][Full Text] [Related]
18. Circularization of
Limberis JD; Nalyvayko A; Ernst JD; Metcalfe JZ
Microbiol Spectr; 2023 Mar; 11(2):e0412722. PubMed ID: 36877083
[TBL] [Abstract][Full Text] [Related]
19. A Multimethod, Multicountry Evaluation of Breakpoints for Bedaquiline Resistance Determination.
Ismail NA; Aono A; Borroni E; Cirillo DM; Desmaretz C; Hasan R; Mitarai S; Shakoor S; Torrea G; Kaniga K; Omar SV
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32660992
[TBL] [Abstract][Full Text] [Related]
20. Site-directed mutagenesis of Mycobacterium tuberculosis and functional validation to investigate potential bedaquiline resistance-causing mutations.
Otum CC; Rivière E; Barnard M; Loubser J; Williams MJ; Streicher EM; Van Rie A; Warren RM; Klopper M
Sci Rep; 2023 Jun; 13(1):9212. PubMed ID: 37280265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
